Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

25,383 total articles

Morgan Stanley Posts Record Quarter but Shares Slip in Pre-Market

Morgan Stanley Posts Record Quarter but Shares Slip in Pre-Market

Morgan Stanley reported a landmark quarter with record revenue of $21.35 billion, $3.46 in earnings per share, a 69% jump in equity trading revenue to $6.3 billion, and strong wealth-management inflows. Despite those results, the stock fell 1.3% in pre-open trading as stretched valuation and an already-elevated market left investors taking profits.

Merck Shares Jump After Dual Trial Successes Bolster Keytruda Outlook

Merck Shares Jump After Dual Trial Successes Bolster Keytruda Outlook

Merck shares moved higher in pre-market trading after its KEYNOTE-C93 Phase 3 trial met the primary endpoint for progression-free survival in mismatch repair deficient advanced or recurrent endometrial cancer, and a partner-led Phase 3 study combining sacituzumab tirumotecan with pembrolizumab also met its primary endpoint in PD-L1 negative non-sma…

Insider Transactions Roundup: Netskope Draws Heavy Buying, Executives at Big Tech and Chipmakers Trim Stakes

Insider Transactions Roundup: Netskope Draws Heavy Buying, Executives at Big Tech and Chipmakers Trim Stakes

Insider filings disclosed on Tuesday show concentrated purchasing at Netskope Inc led by a director and a 10% owner, while a string of senior executives and directors at major technology and semiconductor firms disclosed sizable sales. The filings include open-market buys, purchases by entities tied to large shareholders, and sales executed under R…

Merck Shares Rise After Partner's Lung Cancer Trial Meets Primary Goal

Merck Shares Rise After Partner's Lung Cancer Trial Meets Primary Goal

Merck & Co. shares gained following Kelun-Biotech's announcement that a late-stage study of the experimental antibody-drug conjugate sac-TMT, when given with Merck's immunotherapy Keytruda, met its primary endpoint in first-line advanced lung cancer patients without PD-L1 expression. The combination improved progression-free outcomes versus Keytrud…

Summer Sale Puts AI Stock Picks and Research Tools at Deep Discount — ProPicks AI July List Now Live

Summer Sale Puts AI Stock Picks and Research Tools at Deep Discount — ProPicks AI July List Now Live

As Q2 earnings roll in and geopolitical tensions persist in the Middle East, institutional flows have shifted away from extended mega-cap positions into semiconductor infrastructure, healthcare, and energy. InvestingPro is marking the moment with a limited-time Summer Sale that cuts subscription pricing by up to 60% and makes its ProPicks AI July s…

Analyst: Memory Stock Selloff Signals a Long-Term Buying Window

Analyst: Memory Stock Selloff Signals a Long-Term Buying Window

KB Securities told investors that the recent plunge in a major memory stock represents a buying opportunity over the long term, contending the drop stems from weakening sentiment rather than a change in industry fundamentals. The firm highlights an upcoming, severe DRAM shortage driven by heavy investment in high-bandwidth memory (HBM) and expects …

Kepler Cheuvreux Moves Sandvik to Hold as Rally Narrows Valuation Gap

Kepler Cheuvreux Moves Sandvik to Hold as Rally Narrows Valuation Gap

Kepler Cheuvreux cut its recommendation on Sandvik to hold from buy after the mining and machining group’s stock climbed nearly 70% over the past year, narrowing its discount to Nordic quality peers. The broker raised its price target to 400 Swedish crowns and updated sales and earnings forecasts while flagging caution about whether recent machinin…

BofA Reports Surge in Financials Inflows as Q2 Earnings Season Begins

BofA Reports Surge in Financials Inflows as Q2 Earnings Season Begins

Bank of America clients increased allocations to U.S. equities for a second consecutive week, driven by heavy institutional buying. Single-stock purchases reached $5.1 billion - the third-largest weekly total since 2008 - while equity ETFs attracted $1.8 billion. Financials posted the largest sector-level single-stock inflows in more than a decade …